A detailed history of Israel Englander (Millennium Management LLC) transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 18,536 shares of RNA stock, worth $836,529. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,536
Previous 125,375 85.22%
Holding current value
$836,529
Previous $5.12 Million 83.38%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$37.21 - $48.14 $3.98 Million - $5.14 Million
-106,839 Reduced 85.22%
18,536 $851,000
Q2 2024

Aug 14, 2024

SELL
$22.73 - $40.85 $982,299 - $1.77 Million
-43,216 Reduced 25.63%
125,375 $5.12 Million
Q1 2024

May 15, 2024

SELL
$9.16 - $25.52 $1.58 Million - $4.39 Million
-172,025 Reduced 50.5%
168,591 $4.3 Million
Q4 2023

Feb 14, 2024

BUY
$4.87 - $9.37 $1.44 Million - $2.77 Million
295,476 Added 654.58%
340,616 $3.08 Million
Q2 2023

Aug 14, 2023

BUY
$10.62 - $17.34 $479,386 - $782,727
45,140 New
45,140 $500,000
Q4 2022

Feb 14, 2023

BUY
$10.06 - $22.66 $7.16 Million - $16.1 Million
711,532 Added 1828.52%
750,445 $16.7 Million
Q3 2022

Nov 14, 2022

BUY
$15.46 - $23.43 $601,594 - $911,731
38,913 New
38,913 $635,000
Q1 2022

May 16, 2022

SELL
$14.2 - $23.78 $270,552 - $453,080
-19,053 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$20.4 - $28.66 $75,337 - $105,841
3,693 Added 24.04%
19,053 $453,000
Q3 2021

Nov 15, 2021

BUY
$18.16 - $25.21 $131,841 - $183,024
7,260 Added 89.63%
15,360 $378,000
Q2 2021

Aug 16, 2021

SELL
$19.62 - $29.26 $1.67 Million - $2.49 Million
-84,996 Reduced 91.3%
8,100 $200,000
Q1 2021

May 17, 2021

SELL
$20.28 - $28.15 $225,513 - $313,028
-11,120 Reduced 10.67%
93,096 $2.03 Million
Q4 2020

Feb 16, 2021

BUY
$24.73 - $35.12 $2.58 Million - $3.66 Million
104,216 New
104,216 $2.66 Million
Q3 2020

Nov 16, 2020

SELL
$23.35 - $35.94 $5.28 Million - $8.12 Million
-226,044 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$26.62 - $31.5 $6.02 Million - $7.12 Million
226,044 New
226,044 $6.39 Million

Others Institutions Holding RNA

About Avidity Biosciences, Inc.


  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $2.35B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.